KINTOR PHARMACEUTICAL LIMITED (09939) Announces Monthly Return as of January 31, 2026

Bulletin Express02-02

KINTOR PHARMACEUTICAL LIMITED disclosed its monthly return for equity securities on The Stock Exchange of Hong Kong Limited for the period ended January 31, 2026. According to the announcement, the authorized share capital remained at 700,000,000 ordinary shares with a par value of USD 0.0001 each, totaling USD 70,000. This figure remained unchanged compared to the close of the preceding month.

The announcement confirmed that the total number of issued shares, excluding treasury shares, stood at 498,660,100, with no change from the preceding month. The company also indicated compliance with the applicable public float requirement, which is 25% of the total issued shares. The document noted no new share options, warrants, convertibles, or other arrangements related to the issuance of shares during this period.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment